IMPEL PHARMACEUTICALS INC: capex

Value{"amount": 116000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2021-01-01 – 2021-06-30
Statuscurrent
EntityIMPEL PHARMACEUTICALS INC
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0000950170-21-001473 · Open the official SEC filing →
Retrieved: 2026-08-19T14:16:28.588953+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0001445499/capex/2021-06-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/8a7eac65-dfd2-4c21-a32f-8961b2e6460b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies